Dr. William C. Spanos
Claim this profileAvera Cancer Institute
Studies Cancer
Studies Oropharyngeal Cancer
5 reported clinical trials
13 drugs studied
Area of expertise
1Cancer
p16 positive
p16 negative
HPV positive
2Oropharyngeal Cancer
p16 positive
p16 negative
HPV positive
Affiliated Hospitals
Clinical Trials William C. Spanos is currently running
High-Dose vs Low-Dose Cisplatin with Radiation
for Head and Neck Cancer
This phase II/III trial compares the effect of the combination of high-dose cisplatin every three weeks and radiation therapy versus low-dose cisplatin weekly and radiation therapy for the treatment of patients with locoregionally advanced head and neck cancer. Chemotherapy drugs, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. This study is being done to find out if low-dose cisplatin given weekly together with radiation therapy is the same or better than high-dose cisplatin given every 3 weeks together with radiation therapy in treating patients with head and neck cancer.
Recruiting1 award Phase 2 & 335 criteria
Sentinel Lymph Node Biopsy vs Neck Dissection
for Oral Cancer
This phase II/III trial studies how well sentinel lymph node biopsy works and compares sentinel lymph node biopsy surgery to standard neck dissection as part of the treatment for early-stage oral cavity cancer. Sentinel lymph node biopsy surgery is a procedure that removes a smaller number of lymph nodes from your neck because it uses an imaging agent to see which lymph nodes are most likely to have cancer. Standard neck dissection, such as elective neck dissection, removes many of the lymph nodes in your neck. Using sentinel lymph node biopsy surgery may work better in treating patients with early-stage oral cavity cancer compared to standard elective neck dissection.
Recruiting1 award Phase 2 & 3
More about William C. Spanos
Clinical Trial Related2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments William C. Spanos has experience with
- Cisplatin
- Umbilical Cord Lining Stem Cells (ULSC)
- Intensity-Modulated Radiation Therapy
- Nivolumab
- Computed Tomography (CT)
- Neck Dissection
Breakdown of trials William C. Spanos has run
Cancer
Oropharyngeal Cancer
Squamous Cell Carcinoma
Coronavirus
Coronavirus Infection
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does William C. Spanos specialize in?
William C. Spanos focuses on Cancer and Oropharyngeal Cancer. In particular, much of their work with Cancer has involved p16 positive patients, or patients who are p16 negative.
Is William C. Spanos currently recruiting for clinical trials?
Yes, William C. Spanos is currently recruiting for 2 clinical trials in Sioux Falls South Dakota. If you're interested in participating, you should apply.
Are there any treatments that William C. Spanos has studied deeply?
Yes, William C. Spanos has studied treatments such as Cisplatin, Umbilical Cord Lining Stem Cells (ULSC), Intensity-Modulated Radiation Therapy.
What is the best way to schedule an appointment with William C. Spanos?
Apply for one of the trials that William C. Spanos is conducting.
What is the office address of William C. Spanos?
The office of William C. Spanos is located at: Avera Cancer Institute, Sioux Falls, South Dakota 57105 United States. This is the address for their practice at the Avera Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.